Non-Performing Assets / Total Loans: A classification used by financial institutions that refer to loans that are in jeopardy of default as a potion of total loans made. Calculated as: Non-Perfroming Assets / Gross Loans Made
Xilio Therapeutics, Inc. (XLO) Non-Performing Assets / Total Loans data is not available.
| Income Statement Financials | |
$18.69M |
|
$-6.37M |
|
-- |
|
$18.69M |
|
$22.18M |
|
$-3.49M |
|
$-2.88M |
|
$-6.37M |
|
$-6.37M |
|
$-6.37M |
|
$-6.37M |
|
$-6.37M |
|
$-6.37M |
|
$-3.49M |
|
$-3.16M |
|
19.40M |
|
19.40M |
|
$-0.33 |
|
$-0.33 |
|
| Balance Sheet Financials | |
$145.47M |
|
$3.36M |
|
$8.79M |
|
$154.25M |
|
$34.20M |
|
-- |
|
$47.79M |
|
$81.99M |
|
$72.26M |
|
$72.26M |
|
$72.26M |
|
6.58M |
|
| Cash Flow Statement Financials | |
$-41.10M |
|
$-0.57M |
|
$40.20M |
|
$139.34M |
|
$137.86M |
|
$-1.48M |
|
$3.81M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.25 |
|
|
Non-Performing Assets / Total Loans |
-- |
-- |
|
-- |
|
-- |
|
100.00% |
|
-18.68% |
|
-18.68% |
|
-- |
|
-34.09% |
|
-34.09% |
|
$-41.68M |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
-- |
|
3.12 |
|
28.89 |
|
-8.82% |
|
-8.82% |
|
-4.13% |
|
-8.82% |
|
$10.98 |
|
$-2.15 |
|
$-2.12 |
|